Acupuncture timing may be key to preventing dry mouth in head and neck cancer patients
NCT ID NCT07674706
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This trial compares early versus delayed acupuncture to reduce dry mouth caused by chemoradiation in head and neck cancer patients. Participants receive acupuncture either during chemoradiation or after, and their dry mouth symptoms are tracked for a year. The goal is to find the most effective timing for this complementary therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- acupuncture
- What this could lead to
- If it works, this could point toward the best timing for acupuncture to prevent or reduce severe dry mouth during cancer treatment.
- What could go wrong
- This is a small pilot study, so results may not apply broadly. Acupuncture during chemoradiation carries a small risk of infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Haematology-Oncology, National University Hospital
Singapore, 119074, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could avoiding Pre-Radiation tooth removal protect jaw health?
- Can a blood test and MRI tailor cancer therapy to each patient?
- Radiation's hidden toll: could it link tinnitus and hearing loss in cancer survivors?
- Can an immunotherapy boost standard treatment for a Head-and-Neck cancer?
- Can less radiation be safer for throat cancer?
- Can a Two-Pronged radiation strategy boost immunotherapy against advanced nasopharyngeal cancer?